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Cell cycle dysregulation and neurodegenerative diseasesAdult neurons in the brain are generally thought of as being
in a state of terminal differentiation, effectively precluded from
cell division. Around a decade ago, however, rather surprising
findings were made by several different groups showing that, in
Alzheimer disease, susceptible cortical and hippocampal
neurons display an activated cell cycle phenotype. Notably,
markers from every phase of the cell cycle were ectopically
present in both lesion-bearing neurons and vulnerable neurons,
suggesting that neurons in AD re-enter the cell cycle. Such cell
cycle re-entry is also apparent in other neurodegenerative
diseases, suggesting that the cell cycle re-entry hypothesis may
be a key event in many disease processes. That a mitotic cell-
cycle-related mechanism may play an important role in disease
pathogenesis is highlighted by the earlier occurrence of cell
cycle proteins compared to abnormal tau in AD and by their
appearance at the very earliest prodrominal phase of disease
(i.e., mild cognitive impairment). Furthermore, that cell cycle
proteins are representative of a true cell cycle, rather than being
epiphenomena of other processes, is supported by evidence
showing that, in AD and other neurodegenerative diseases, a
true mitotic alteration leads to DNA replication (i.e., S phase).
However, until recently, the heavy reliance of human post-
mortem brain tissues made it impossible to address the cause
and consequence of neuronal cell cycle re-entry as well as its
relationship with other pathologically important molecules.
Nonetheless, recent progress with animal models supports the
cell cycle concept to such an extent that therapeutics based on
stopping cell cycle re-entry are now being envisioned.
In this special issue on cell cycle and neurodegeneration,
we have been fortunate to gather some of the most foremost0925-4439/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbadis.2007.01.012experts in the field to discuss up-to-date information
concerning new developments in this exciting area of research
as well as their therapeutic implications. We thank these
contributors for their scholarship and also owe a great debt of
gratitude to Dr. Paul Fraser for the opportunity to compile this
issue. It is our sincere hope that this issue proves to be a
timely resource to all those who are interested in neuronal cell
cycle in neurodegeneration.
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